Biovail won't expense options yet, CEO says

Article Abstract:

Eugene Melnyk, the chief executive of Biovail Corp., said that the company would not expense its stock options for the time being. However, Melnyk said that Biovail would follow standards for option expensing once the pharmaceutical industry establishes them.

Executive changes & profiles, Securities issued, listed, Officials and employees, Stock options, Beliefs, opinions and attitudes, Securities, Chief executive officers, Company securities

---

Shakeup expected at Biovail's U.S. unit

Article Abstract:

Biovail Corp. is planning a corporate reorganization of its U.S. unit following heavy losses. The details of the company's plans are presented.

Organizational history, Pharmaceutical preparations, Company restructuring/company reorganization, Reorganization and restructuring, Company organization

---

Biovail boss takes new tack on drugs

Article Abstract:

Biovail Corp.'s controlled-release technology could improve how brand-name drugs fight illness.

Drugs & Pharmaceuticals, Pharmaceutical and Medicine Manufacturing, Drugs, Brief Article

Similar abstracts:

• Abstracts: New salmon deal a sellout, Clark says. MDs will dispense marijuana. Firms wrestle China's red tape
• Abstracts: Xbox chip rumour lifts ATI shares. ATI shares slide almost 9% after rating cut. Hirsch fund takes refuge in safer havens
• Abstracts: Profitable relationships. Streams of retirement. Pension daze
• Abstracts: A.G. Simpson gets creditor protection. Stelco assures union it plans to avoid protection. Stelco plan calls for $200 - million injection
• Abstracts: Internet piracy is suspected as U.S. agents raid campuses. BUSH PRESSURING G.O.P. TO APPROVE INTELLIGENCE BILL

This website is not affiliated with document authors or copyright owners. This page is provided for informational purposes only. Unintentional errors are possible.